DailyDoctor Archive Specialties Get app
All neurology briefings

The edition · Neurology

Lamotrigine levels fall by two-thirds by the third trimester, and treating amyloid neuropathy early beats treating it well

A 947-woman Chinese cohort quantifies how far each antiseizure drug drops in pregnancy, CSF amyloid tracks the severity of cerebral amyloid angiopathy better than microbleed counts, and plasma p-tau217 explains part of the cognitive decline in late-onset unexplained epilepsy.

The edition in brief

In a prospective multicentre Chinese cohort of 947 women with epilepsy contributing 1,638 samples, concentration-to-dose ratios fell steeply in pregnancy. Lamotrigine dropped 28.8%, 54.3% and 63.2% across the three trimesters, reaching a nadir of -65.8% at 32 weeks. Levetiracetam fell 26.2%, 40.1% and 31.0%, with a nadir of -35.5% at 24 weeks; the oxcarbazepine metabolite fell 23.1%, 32.6% and 44.3%; lacosamide fell 10.8% in the second trimester. Concomitant drugs shifted baseline ratios without changing the gestational trajectory, and interindividual variability dominated everything measured. In 102 patients with probable cerebral amyloid angiopathy by Boston criteria v2.0, lower CSF amyloid-beta 40 and 42 were associated with greater cortical superficial siderosis (standardised beta -0.49 and -0.42) and higher Fazekas score, but not with lobar microbleed count. Tau species showed no association with any MRI marker, and the findings held after stratifying by an Alzheimer-like amyloid profile. Among 85 people with late-onset unexplained epilepsy, higher plasma p-tau217 was associated with poorer cognition (beta -0.66, 95% CI -1.19 to -0.13), worst in those with medication-refractory epilepsy. About 24% of that association was accounted for by reduced spindle-slow oscillation coupling on sleep EEG. A double-blind sham-controlled trial of dual transcranial direct current stimulation in 74 patients with post-stroke cognitive impairment improved Montreal Cognitive Assessment scores by 5.74 points against 2.69 with sham. A post hoc analysis of NEURO-TTRansform found eplontersen maintained neuropathy scores across all baseline severity tertiles, while historical placebo worsened.

In this edition
01
Clinical update

By 32 weeks, a lamotrigine dose is doing a third of the work it did before pregnancy

Lamotrigine concentration-to-dose ratios fall by about two-thirds by 32 weeks and levetiracetam by about a third by 24 weeks, so measure each trimester and titrate against the woman's own preconception level.

2 min · NeurologyRead →
Primary outcome
Gestational change in antiseizure medication concentration-to-dose ratio by trimester
Effect
Lamotrigine -28.8%, -54.3%, -63.2% by trimester (nadir -65.8% at 32 weeks); levetiracetam -26.2%, -40.1%, -31.0% (nadir -35.5% at 24 weeks); oxcarbazepine metabolite -23.1%, -32.6%, -44.3%; lacosamide -10.8% in the second trimester
02Clinical update

In cerebral amyloid angiopathy, CSF amyloid tracks the siderosis rather than the microbleeds

Lower CSF amyloid-beta tracked cortical superficial siderosis and white matter burden in cerebral amyloid angiopathy but not microbleed count, so siderosis is the better severity marker on the scan you already have.

2 min · NeurologyRead →
03Research

In late-onset epilepsy of no clear cause, sleep spindles carry part of the cognitive decline

In late-onset unexplained epilepsy, higher plasma p-tau217 was associated with worse cognition, especially with refractory seizures, so assess cognition and sleep rather than attributing decline to medication.

2 min · NeurologyRead →
04Research

Prefrontal tDCS improved cognition after stroke, in 74 patients

Dual prefrontal transcranial direct current stimulation improved Montreal Cognitive Assessment scores by about three points over sham after stroke, but on 74 patients with no reported follow-up beyond treatment.

2 min · CNS neuroscience & therapeuticsRead →
05Pearl

Write the postpartum dose reduction on the same prescription as the increase

Write the postpartum taper on the same prescription as the antenatal dose increase, with a dated plan in the woman's hand and a booked level - otherwise the raised dose stays after the levels have returned.

1 minRead →
06
Practice changer

Eplontersen held neuropathy scores steady whatever the starting severity, which is an argument for starting early

Eplontersen maintained neuropathy, quality of life and nutritional scores across every baseline severity tertile in hereditary transthyretin amyloidosis, so treat early - the function preserved is the function the patient still has.

2 min · Journal of the peripheral nervous system : JPNSRead →
Primary outcome
Neuropathy impairment (modified NIS+7), quality of life, physical functioning, nutritional status and transthyretin levels at 65-85 weeks
Effect
Mean modified NIS+7 change -4.5, -1.3 and -2.6 points across increasing severity tertiles, all maintained; placebo worsened across outcomes

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for neurology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free